EGFR and neoplasm: The possible mechanisms are as follows: better improving the imbalance of T lymphocyte subsets and increasing the frequency of Tregs in peripheral blood of tumor patients19, blocking EGFR and inhibiting EGFR phosphorylation20, increasing apoptosis and G2/M phase arrest21.